KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding KALA BIO, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 33 | 1 | 29 | −3 |
| Shares | 3.46M | 10 | 4.14M | +680.9K (+19.7%) |
| Value | $24.0M | $111 | $23.7M | −$284.7K (−1.2%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held KALA BIO, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 277,610 | $1.59M | 0.06% |
| Woodline Partners LP | 258,766 | $1.48M | 0.01% |
| Readystate Asset Management LP | 42,459 | $243.3K | 0.01% |
| Northern Trust Corp | 10,399 | $59.6K | 0.00% |
| Cheviot Value Management, LLC | 153 | $555 | 0.00% |
| Binnacle Investments Inc | 8 | $46 | 0.00% |
Sold out (9)
Institutions that held KALA BIO, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Millennium Management LLC | 136,056 | $944.2K |
| Board of Trustees of The Leland Stanford Junior University | 21,127 | $146.6K |
| Two Sigma Investments, LP | 11,877 | $82.4K |
| Citigroup Inc | 5,676 | $39.4K |
| Compagnie Lombard Odier SCmA | 400 | $2.78K |
| CWM, LLC | 200 | $1.00K |
| Advisor Group Holdings, Inc. | 100 | $694 |
| Group One Trading, L.P. | 22 | $153 |
| Royal Bank of Canada | 2 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held KALA BIO, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Legacy Investment Solutions, LLC | 10 | $111 |